Back to Novo Holdings A/S
Q3 2026 13F filing
Updated 6 days ago27 disclosed positions worth $1.5B
Portfolio value
$1.5B
Total holdings
27
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EDGEWISE THERAPEUTICS INC | $217.2M | 5.35M | 14.58% | — |
| 2 | A ASML HOLDING N V | $172M | 94.9K | 11.55% | — |
| 3 | B BROOKFIELD CORP | $162.8M | 4.47M | 10.93% | — |
| 4 | C HEMAB THERAPEUTICS HLDGS INC | $128.9M | 4.18M | 8.65% | — |
| 5 | A AVALYN PHARMACEUTICALS INC | $98.3M | 3.45M | 6.60% | — |
| 6 | M MIRUM PHARMACEUTICALS INC | $96.2M | 1.13M | 6.46% | — |
| 7 | C SALESFORCE INC | $90.3M | 393.2K | 6.06% | — |
| 8 | E ENLIVEN THERAPEUTICS INC | $45.8M | 1.00M | 3.08% | — |
| 9 | F 4D MOLECULAR THERAPEUTICS IN | $42.9M | 3.00M | 2.88% | — |
| 10 | O OBSIDIAN THERAPEUTICS INC | $42.9M | 3.12M | 2.88% | — |
| 11 | P VAXCYTE INC | $40.4M | 710.0K | 2.71% | — |
| 12 | F FLOOR & DECOR HLDGS INC | $36.5M | 797.0K | 2.45% | — |
| 13 | V VIRIDIAN THERAPEUTICS INC | $36M | 1.75M | 2.42% | — |
| 14 | A ARRIVENT BIOPHARMA INC | $35.6M | 1.18M | 2.39% | — |
| 15 | I INSMED INC | $32.5M | 284.4K | 2.18% | — |
| 16 | P PHARVARIS N V | $32.3M | 1.02M | 2.17% | — |
| 17 | C CELLDEX THERAPEUTICS INC NEW | $30.8M | 950.0K | 2.07% | — |
| 18 | B ALIBABA GROUP HLDG LTD | $27.7M | 257.3K | 1.86% | — |
| 19 | X XENON PHARMACEUTICALS INC | $24.3M | 652.1K | 1.63% | — |
| 20 | S SCHOLAR ROCK HLDG CORP | $22.2M | 460.0K | 1.49% | — |
| 21 | D DYNE THERAPEUTICS INC | $22.2M | 1.38M | 1.49% | — |
| 22 | M MAPLIGHT THERAPEUTICS INC | $21.3M | 2.09M | 1.43% | — |
| 23 | C CONTINEUM THERAPEUTICS INC | $9.4M | 704.0K | 0.63% | — |
| 24 | A ALUMIS INC | $9.2M | 1.25M | 0.62% | — |
| 25 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $9.2M | 2.25M | 0.62% | — |
| 26 | M MARQETA INC | $1.9M | 110.4K | 0.13% | — |
| 27 | ? N/A LANZATECH GLOBAL INC | $903K | 158.1K | 0.06% | — |